Pancreatic Cancer Research News and Journal Articles
News In this weeks news: Peregrine’s cancer drug data disappoints; shares plunge | Reuters Peregrine Pharmaceuticals (PPHM.O) said an independent assessment of data from a mid-stage trial showed unexpectedly high progression-free survival rates in lung cancer patients receiving standard chemotherapy, raising doubts about the future of its lung cancer trial. Boulder-based Clovis Oncology reports 2011 […]
Pancreatic Cancer Research News and Journal Articles Read More »
